Pharma Logistics White Papers & Articles
-
Bulletproof Supply Chain: Hope For The Best, Prepare For The Worst
8/3/2021
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.
-
Manufacturing Vaccines During COVID-19: CMOs/CDMOs To The Rescue
7/16/2021
Understand what goes into producing a vaccine, raw materials, technology, and a complex manufacturing process, and how and why CMOs and CDMOs are better positioned to bridge the gap between vaccine demand and supply, safely and at speed.
-
How Forecasting Supports The Integrity Of The Biopharma Supply Chain
6/30/2021
Receiving customer forecasts as early and completely as possible is critical to the success of the supply chain continuum.
-
Overcoming Cell Therapy Supply Chain Challenges
5/11/2021
For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
-
The Science Of Cell Therapy Thawing
4/5/2021
A summary of the science of thawing following conventional slow freezing methods, the physical and biological implications of key metrics and components, and key studies from scientific literature.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
3/29/2021
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Enabling Fast, Appropriate Drug Product Supply For Phase 1 Trials
10/30/2020
Without the ability to move smoothly from lab concept to manufacture to delivery of GMP clinical supplies to patients, critical milestones could be missed, delaying funding commitments from investors.
-
Standardizing Biosample Management - Why Use Collection Kits?
2/11/2019
Whether conducting a phase 3 clinical trial of a new therapy or looking for biomarkers, you will need to collect samples.These basics of planning sample collection will help make the process cost-effective.
-
Off-Site Storage Of Biological Specimens And Biologics For Risk Mitigation
2/11/2019
Choosing an offsite storage facility means asking the right questions to determine if the storage provider has the appropriate risk mitigation infrastructure in place, beginning with a realistic threat assessment.
-
Cold Chain Qualification: 5 Questions You Must Ask When Shipping Biologics
2/11/2019
Patient safety and regulatory compliance are the key drivers within cold chain logistical systems, and organizations recognize the growing need for control of the entire cold chain. The ever-changing global scenario requires highly efficient processes as a backbone to accommodate the growing needs of organizations.